For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety ...
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.
Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, ...
On day 20, anti-AChR returned strongly positive, confirming myasthenia gravis (table 1). Treatment with pyridostigmine was initiated, leading to the normalisation of ptosis, diplopia and eye movements ...
Two-thirds of patients had a positive HEp-2 IIF nuclear pattern (all with titers ≥1/320), defining three novel scleromyositis subsets. First, antinuclear antibody (ANA)-negative scleromyositis was ...
Graviss Hospitality Ltd., incorporated in the year 1959, is a Small Cap company (having a market cap of Rs 343.01 Crore) operating in Tourism & Hospitality sector. Graviss Hospitality Ltd. key ...
This daily column at GNN.org features all the good news, anniversaries and notable birthdays from this day in history—February 13.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback